Tinghu Qiu - Publications

Affiliations: 
National Institutes of Health, Bethesda, MD 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Amin R, Ha NH, Qiu T, Holewinski R, Lam KC, Lopès A, Liu H, Tran AD, Lee MP, Gamage ST, Andresson T, Goldszmid RS, Meier JL, Hunter KW. Loss of NAT10 disrupts enhancer organization via p300 mislocalization and suppresses transcription of genes necessary for metastasis progression. Biorxiv : the Preprint Server For Biology. PMID 38410432 DOI: 10.1101/2024.01.24.577116  0.335
2020 Ross C, Szczepanek K, Lee M, Yang H, Qiu T, Sanford J, Hunter K. The genomic landscape of metastasis in treatment-naïve breast cancer models. Plos Genetics. 16: e1008743. PMID 32463822 DOI: 10.1371/Journal.Pgen.1008743  0.448
2019 Li H, Tan L, Zhang JW, Chen H, Liang B, Qiu T, Li QS, Cai M, Zhang QH. Quercetin is the Active Component of Yang-Yin-Qing-Fei-Tang to Induce Apoptosis in Non-Small Cell Lung Cancer. The American Journal of Chinese Medicine. 47: 879-893. PMID 31179723 DOI: 10.1142/S0192415X19500460  0.319
2019 Chen X, Qiu T, Zhu Y, Sun J, Li P, Wang B, Lin P, Cai X, Han X, Zhao F, Shu Y, Chang L, Jiang H, Gu Y. A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer. The Oncologist. PMID 30877190 DOI: 10.1634/theoncologist.2019-0164  0.304
2016 Aprelikova O, Tomlinson CC, Hoenerhoff M, Hixon JA, Durum SK, Qiu TH, He S, Burkett S, Liu ZY, Swanson SM, Green JE. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases. Plos One. 11: e0155262. PMID 27171183 DOI: 10.1371/Journal.Pone.0155262  0.468
2016 Aprelikova O, Chen K, El Touny LH, Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M, Green JE. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Clinical Epigenetics. 8: 38. PMID 27081402 DOI: 10.1186/S13148-016-0205-6  0.475
2016 Ramirez LV, Bilke S, Walker R, Meltzer P, Qiu T, Rad R, Green JE. Abstract 1576: Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis Cancer Research. 76: 1576-1576. DOI: 10.1158/1538-7445.Am2016-1576  0.472
Show low-probability matches.